During the past couple weeks, as contentious negotiations over spending legislation heated up, then came to a head in the form of a federal government shutdown, two separate announcements from the Trump Administration may have flown under the radar, but are now rippling through the healthcare industry nonetheless: one centered on a dramatic increase in the cost of H-1B visa fees, while the other marked the launch of a new prescription drug pricing platform, TrumpRx.com.
While both initiatives are framed as efforts to protect American jobs and reduce consumer costs, healthcare leaders warn they could have unintended consequences for patient care and access.
President Trump’s recent declaration that a $100,000 fee will now accompany H-1B visa applications has drawn criticism from some healthcare experts and professional societies.
The H-1B visa program has long served as a critical pipeline for foreign-trained medical professionals, particularly in underserved and rural areas, where physician shortages are most severe.
Health systems such as the Mayo Clinic and St. Jude Children’s Research Hospital are among the most frequent users of the H-1B program. These institutions rely on international medical graduates to fill essential roles, especially in specialties and geographic areas with a scarcity of homegrown providers.
In the past year, nearly 17,000 H-1B visas were granted to medical professionals, including surgeons and new medical graduates. And a recent study found that 64 percent of these foreign-trained providers practice in underserved or rural communities, highlighting the program’s importance in addressing healthcare disparities.
The American Medical Association (AMA) and other medical groups have urged the Administration to exempt healthcare workers from the fee increase, saying that the new cost burden could discourage hospitals from sponsoring international physicians, making the current staffing shortages even worse and putting patient care at risk.
In a separate move last week, the Trump Administration unveiled TrumpRx.com, a new platform aimed at helping consumers access lower-priced prescription drugs.
While the announcement has generated interest, there are plenty of questions about what exactly the platform actually does, how it works, and whether its goals are achievable. For example, it’s unclear which medications will be available through TrumpRx.com, or whether consumers will be able to use their insurance to pay for them.
The Administration has positioned the platform as an alternative to traditional pharmacy pricing, wherein consumers can buy drugs directly from manufacturers, bypassing insurance and pharmacy benefit managers (PBMs), but some healthcare analysts are saying that without transparency and the ability to work smoothly with existing payer systems, its impact may be limited.
Initial reactions from industry observers have been mixed. Some see the platform as a step toward greater price competition. Others worry it might actually slow down progress toward a more meaningful fix for the larger prescription drug pricing problem.
Together, the H1-B visa and TrumpRx initiatives underscore the Trump Administration’s broader approach to healthcare policy – one that continues to emphasize cost-cutting and reliance on an American workforce.
In the leadup to the government shutdown, and during the shutdown itself, the Administration isn’t shutting down at all; it’s launching initiatives that may impact the healthcare industry for years to come.
So, as these policies take shape, stay tuned, because stakeholders across the healthcare continuum will be assessing their impact, not just on budgets, but on the quality and accessibility of care for millions of Americans.
EDITOR’S NOTE: The author of this article used AI-assisted tools in its composition, but all content, analysis, and conclusions were based on the author’s professional
In January 2026, the White House released a fact sheet announcing a call by Donald J. Trump for Congress to enact the “Great Healthcare Plan.”
Please log in to your account to comment on this article.
Sepsis sequencing continues to challenge even experienced coding and CDI professionals, with evolving guidelines, documentation gaps, and payer scrutiny driving denials and data inconsistencies. In this webcast, Payal Sinha, MBA, RHIA, CCDS, CDIP, CCS, CCS-P, CCDS-O, CRC, CRCR, provides clear guideline-based strategies to accurately code sepsis, severe sepsis, and septic shock, assign POA indicators, clarify the relationship between infection and organ dysfunction, and align documentation across teams. Attendees will gain practical tools to strengthen audit defensibility, improve first-pass accuracy, support appeal success, reduce denials, and ensure accurate quality reporting, empowering organizations to achieve consistent, compliant sepsis coding outcomes.
Expert presenters Kathy Pride, RHIT, CPC, CCS-P, CPMA, and Brandi Russell, RHIA, CCS, COC, CPMA, break down complex fracture care coding rules, walk through correct modifier application (-25, -57, 54, 55), and clarify sequencing for initial and subsequent encounters. Attendees will gain the practical knowledge needed to submit clean claims, ensure compliance, and stay one step ahead of payer audits in 2026.
Accurately determining the principal diagnosis is critical for compliant billing, appropriate reimbursement, and valid quality reporting — yet it remains one of the most subjective and error-prone areas in inpatient coding. In this expert-led session, Cheryl Ericson, RN, MS, CCDS, CDIP, demystifies the complexities of principal diagnosis assignment, bridging the gap between coding rules and clinical reality. Learn how to strengthen your organization’s coding accuracy, reduce denials, and ensure your documentation supports true medical necessity.
Denials continue to delay reimbursement, increase administrative burden, and threaten financial stability across healthcare organizations. This essential webcast tackles the root causes—rising payer scrutiny, fragmented workflows, inconsistent documentation, and underused analytics—and offers proven, data-driven strategies to prevent and overturn denials. Attendees will gain practical tools to strengthen documentation and coding accuracy, engage clinicians effectively, and leverage predictive analytics and AI to identify risks before they impact revenue. Through real-world case examples and actionable guidance, this session empowers coding, CDI, and revenue cycle professionals to shift from reactive appeals to proactive denial prevention and revenue protection.
In this timely session, Stacey Shillito, CDIP, CPMA, CCS, CCS-P, CPEDC, COPC, breaks down the complexities of Medical Decision Making (MDM) documentation so providers can confidently capture the true complexity of their care. Attendees will learn practical, efficient strategies to ensure documentation aligns with current E/M guidelines, supports accurate coding, and reduces audit risk, all without adding to charting time.
Join Ronald Hirsch, MD, FACP, CHCQM for The PEPPER Returns – Risk and Opportunity at Your Fingertips, a practical webcast that demystifies the PEPPER and shows you how to turn complex claims data into actionable insights. Dr. Hirsch will explain how to interpret key measures, identify compliance risks, uncover missed revenue opportunities, and understand new updates in the PEPPER, all to help your organization stay ahead of audits and use this powerful data proactively.
Stay ahead of the 2026-2027 audit surge with “Top 10 Audit Targets for 2026-2027 for Hospitals & Physicians: Protect Your Revenue,” a high-impact webcast led by Michael Calahan, PA, MBA. This concise session gives hospitals and physicians clear insight into the most likely federal audit targets, such as E/M services, split/shared and critical care, observation and admissions, device credits, and Two-Midnight Rule changes, and shows how to tighten documentation, coding, and internal processes to reduce denials, recoupments, and penalties. Attendees walk away with practical best practices to protect revenue, strengthen compliance, and better prepare their teams for inevitable audits.
As AI reshapes healthcare compliance, the risk of biased outputs and opaque decision-making grows. This webcast, led by Frank Cohen, delivers a practical Four-Pillar Governance Framework—Transparency, Accountability, Fairness, and Explainability—to help you govern AI-driven claim auditing with confidence. Learn how to identify and mitigate bias, implement robust human oversight, and document defensible AI review processes that regulators and auditors will accept. Discover concrete remedies, from rotation protocols to uncertainty scoring, and actionable steps to evaluate vendors before contracts are signed. In a regulatory landscape that moves faster than ever, gain the tools to stay compliant, defend your processes, and reduce liability while maintaining operational effectiveness.
Happy National Doctor’s Day! Learn how to get a complimentary webcast on ‘Decoding Social Admissions’ as a token of our heartfelt appreciation! Click here to learn more →
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 1 with code CYBER25
CYBER WEEK IS HERE! Don’t miss your chance to get 20% off now until Dec. 2 with code CYBER24
